Key market opportunities include smart technologies like NFC labels, advances in biologics requiring specialized packaging, and innovations in sustainable and child/senior-friendly designs ...
On February 3, Bio-Thera Solutions signed a licensing and commercialization agreement with Saudi Arabia-based Avalon Pharma, granting it exclusive rights to commercialize BAT3306, a pembrolizumab ...
Mutual of Omaha continues to expand its application programming interface (API) integration offerings for benefits ...
MYQORZO® Approved for Adults with Symptomatic Obstructive HCM in U.S., China and Europe; U.S. Launch Underway with First Prescriptions Dispensed within Days of Drug Availability Supplemental NDA for ...
Three local nonprofits will be up nearly $12,000 in funding if the New Albany City Council votes to distribute some of the ...
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is ...
GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic, Wegovy, Mounjaro, but with reduced risk of adverse events) discovered by researchers at Syracuse University.V ...
GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic®, Wegovy®, Mounjaro®, but with reduced risk of adverse events) discovered by researchers at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results